Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: a FIELD substudy

Benjamin N. Rao, Nicola Quinn, Andrzej S. Januszewski, Tunde Peto, Laima Brazionis, Nanda Aryal, Rachel L. O'Connell, Liping Li, Paula Summanen, Russell Scott, Justin O'Day, Anthony C. Keech, Alicia J. Jenkins, FIELD Trail Study Group

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Aims: To evaluate the risk algorithm by Aspelund et al. for predicting sight-threatening diabetic retinopathy (STDR) in Type 2 diabetes (T2D), and to develop a new STDR prediction model.

Methods: The Aspelund et al. algorithm was used to calculate STDR risk from baseline variables in 1012 participants in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) ophthalmological substudy, compared to on-trial STDR status, and receiver operating characteristic analysis performed. Using multivariable logistic regression, traditional risk factors and fenofibrate allocation as STDR predictors were evaluated, with bootstrap-based optimism-adjusted estimates of predictive performance calculated.

Results: STDR developed in 28 participants. The Aspelund et al. algorithm predicted STDR at 2- and 5-years with area under the curve (AUC) 0.86 (95% CI 0.77–0.94) and 0.86 (0.81–0.92), respectively. In the second model STDR risk factors were any DR at baseline (OR 24.0 [95% CI 5.53–104]), HbA1c (OR 1.95 [1.43–2.64]) and male sex (OR 4.34 [1.32–14.3]), while fenofibrate (OR 0.13 [0.05–0.38]) was protective. This model had excellent discriminatory ability (AUC = 0.89).

Conclusions: The algorithm by Aspelund et al. predicts STDR well in the FIELD ophthalmology substudy. Logistic regression analysis found DR at baseline, male sex, and HbA1c were predictive of STDR and, fenofibrate was protective.
Original languageEnglish
Article number109835
Pages (from-to)1-6
Number of pages6
JournalDiabetes Research and Clinical Practice
Volume186
DOIs
Publication statusPublished - Apr 2022
Externally publishedYes

Bibliographical note

A corrigendum exists for this article and can be found in Diabetes Research and Clinical Practice (2023) Vol. 196, Art. 110234 at doi: 10.1016/j.diabres.2022.110234

Keywords

  • Diabetic retinopathy
  • Validation study
  • Risk calculator
  • Fenofibrate

Fingerprint

Dive into the research topics of 'Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: a FIELD substudy'. Together they form a unique fingerprint.

Cite this